Kanter G - Search Results

1

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.

Varughese LA, Bhupathiraju M, Hoffecker G, Terek S, Harr M, Hakonarson H, Cambareri C, Marini J, Landgraf J, Chen J, Kanter G, Lau-Min KS, Massa RC, Damjanov N, Reddy NJ, Oyer RA, Teitelbaum UR, Tuteja S. Varughese LA, et al. Among authors: kanter g. Front Oncol. 2022 Jul 5;12:859846. doi: 10.3389/fonc.2022.859846. eCollection 2022. Front Oncol. 2022. PMID: 35865463 Free PMC article.

2

Health Care Privacy Risks of AI Chatbots.

Kanter GP, Packel EA. Kanter GP, et al. JAMA. 2023 Jul 25;330(4):311-312. doi: 10.1001/jama.2023.9618. JAMA. 2023. PMID: 37410449

3

Large language model non-compliance with FDA guidance for clinical decision support devices.

Weissman G, Mankowitz T, Kanter G. Weissman G, et al. Among authors: kanter g. Res Sq [Preprint]. 2024 Sep 9:rs.3.rs-4868925. doi: 10.21203/rs.3.rs-4868925/v1. Res Sq. 2024. PMID: 39315257 Free PMC article. Preprint.

4

Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.

Hoffecker G, Kanter GP, Xu Y, Matthai W, Kolansky DM, Giri J, Tuteja S. Hoffecker G, et al. Among authors: kanter gp. Per Med. 2022 Jan;19(1):41-49. doi: 10.2217/pme-2021-0088. Epub 2021 Dec 9. Per Med. 2022. PMID: 34881641

5

Association between oral targeted cancer drug net health benefit, uptake, and spending.

Lau-Min KS, Wu Y, Rochester S, Bekelman JE, Kanter GP, Getz KD. Lau-Min KS, et al. Among authors: kanter gp. J Natl Cancer Inst. 2024 Sep 1;116(9):1479-1486. doi: 10.1093/jnci/djae110. J Natl Cancer Inst. 2024. PMID: 38745430

6

Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers.

Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP. Ko EM, et al. Gynecol Oncol. 2022 Feb;164(2):295-303. doi: 10.1016/j.ygyno.2021.12.001. Epub 2021 Dec 20. Gynecol Oncol. 2022. PMID: 34949437

7

Prior authorization in gynecologic oncology: An analysis of clinical impact.

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM. Smith AJB, et al. Gynecol Oncol. 2022 Dec;167(3):519-522. doi: 10.1016/j.ygyno.2022.10.002. Epub 2022 Oct 14. Gynecol Oncol. 2022. PMID: 36244827

8

Insurance and racial disparities in prior authorization in gynecologic oncology.

Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty A, Ko EM. Smith AJB, et al. Gynecol Oncol Rep. 2023 Mar 11;46:101159. doi: 10.1016/j.gore.2023.101159. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 36942280 Free PMC article.

9

An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery.

Hicks-Courant K, Kanter GP, Giuntoli RL 2nd, Schapira MM, Bekelman JE, Latif NA, Haggerty AF, Morgan MA, Burger R, Ko EM. Hicks-Courant K, et al. Gynecol Oncol. 2021 Jan;160(1):3-9. doi: 10.1016/j.ygyno.2020.10.030. Epub 2020 Nov 24. Gynecol Oncol. 2021. PMID: 33243442

10

Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial.

Adusumalli S, Kanter GP, Small DS, Asch DA, Volpp KG, Park SH, Gitelman Y, Do D, Leri D, Rhodes C, VanZandbergen C, Howell JT, Epps M, Cavella AM, Wenger M, Harrington TO, Clark K, Westover JE, Snider CK, Patel MS. Adusumalli S, et al. Among authors: kanter gp. JAMA Cardiol. 2023 Jan 1;8(1):23-30. doi: 10.1001/jamacardio.2022.4373. JAMA Cardiol. 2023. PMID: 36449275 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters